Generics don’t get an easy ride in Canada
As brand-name producers push for longer data exclusivity and a better appeals process in Canada, Jim Keon, president of the Canadian Generic Pharmaceutical Association, explains the misconceptions about Canadian regulation to Alli Pyrah
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: